Sharemaestro Newsreel

biote Corp. (BTMD) Releases Q2 2026 Earnings: Revenue Declines and EPS Miss

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

agilon health turns a $104M Q2 net loss into $18M net income

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Agilon Health (AGL) Earnings Date and Reports 2026 $AGL

Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

Encompass Health (NYSE:EHC) Issues FY 2026 Earnings Guidance

Encompass Health (EHC) Beats Q2 Earnings and Revenue Estimates

DaVita (DVA) Stock Price Faces Margin Doubts After 17% Sell Off

Is OPCH’s Buybacks Plus Acquisition Hunt Altering The Investment Case For Option Care Health?

Is Option Care Health (OPCH) Stock Undervalued Right Now?

Hospital Chains Stocks Q2 Earnings: Tenet Healthcare (NYSE:THC) Best of the Bunch

DaVita Expands Access to Advanced Middle Molecule Clearance

DaVita is rapidly scaling access to advanced middle molecule clearance therapies like Expanded Hemodialysis (Expanded HD) and continuing hemodiafiltration (HDF) pilots to improve kidney care outcomes. This expansion is driven by the recent FDA approval of Nipro’s ELISIO-HX dialyzer, which allows for greater removal …

InnovAge Holding Corp. SEC Filing (Aug 5, 2026)

InnovAge Holding Corp. announced the effectiveness of its S-3 Shelf Registration Statement on August 4, 2026, at 4:30 PM. This SEC filing was accepted on August 5, 2026, at 6:15 AM ET. The filing indicates the company's ability to offer securities from time to …

Pediatrix Q2 2026 earnings: Reimbursement gains offset volume declines

Pediatrix Medical Group (NYSE: MD) reported a 4.0% year-over-year increase in Q2 2026 net revenue to $487.8 million, driven by recent acquisitions and improved reimbursement rates, despite a decline in patient volumes. While diluted GAAP EPS rose to $0.49, higher operating costs led to …

5 Insightful Analyst Questions From Option Care Health’s Q2 Earnings Call

Option Care Health (OPCH) exceeded Wall Street's expectations in Q2 2026 due to strong organic growth in acute therapies, stabilization in chronic inflammatory disease portfolios, and effective cost control. The earnings call highlighted key analyst questions covering revenue mix impact on margins, the speed …

DaVita Inc. 2026: Revenue $3.55B, EPS $4.02— 10-Q Summary

DaVita Inc. reported strong financial results for the quarter ended 2026, with revenue reaching $3.55 billion and diluted EPS at $4.02, marking significant increases over the prior-year quarter. The growth was primarily driven by higher U.S. dialysis volumes and a substantial increase in ancillary …

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PACS Group

Faruqi & Faruqi, LLP is investigating potential claims against PACS Group, Inc. (NYSE: PACS) on behalf of investors who suffered losses exceeding $50,000. The investigation follows allegations that PACS Group engaged in a scheme to submit false Medicare claims, bill for unnecessary therapies, and …

DaVita's Profit Growth Prospects Boosted by Share Repurchases

DaVita's profit growth is expected to improve due to share repurchases, despite recent challenges from COVID-related mortality and labor pressures. The company, which specializes in services for end-stage renal disease patients, has a large network of dialysis clinics in the US and is expanding …

Innovage Holding Corp Shareholder Alert

Faruqi & Faruqi, LLP is investigating potential claims against Innovage Holding Corp (NASDAQ: INNV) and encourages investors who lost over $50,000 to contact them. The lawsuit alleges that Innovage made misleading statements and failed to disclose that its facilities had service deficiencies, leading to …

What InnovAge Holding (INNV)'s US$1.31 Billion Shelf Registration Plan Means For Shareholders

InnovAge Holding Corp. has filed a shelf registration to potentially issue up to US$1.31 billion in common stock, covering over 112 million shares for future capital needs. This move provides financial flexibility but raises concerns among investors about potential share dilution and the company's …

Pacs Group Inc reports results for the quarter ended June 30 - Earnings Summary

Pacs Group Inc has released its earnings summary for the quarter that ended on June 30. The full article with detailed results is available for subscribers to TradingView, which aggregates news from various sources including Reuters.

Behind Concord Healthcare (2453.HK)'s Positive Profit Alert: Gross Profit Surges More Than 160-Fold as Proton Therapy Enters a New Phase of Scalable Growth

Concord Healthcare (2453.HK) has issued a positive profit alert, projecting a significant increase in gross profit for the first half of 2026, surging over 160-fold year-on-year. This remarkable growth is attributed to its proton therapy infrastructure entering a commercialization stage, with the Guangzhou Concord …

Strata Critical Medical Inc (SRTA) (Q2 2026) Earnings Call Highlights: Revenue Surges 60. ...

Strata Critical Medical Inc (SRTA) reported a 60.7% year-over-year revenue increase to $72.5 million in Q2 2026, driven by strong clinical revenue growth and strategic acquisitions. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, citing outperformance in its base business and …

Viemed Healthcare (VMD) Stock Price Sinks As Margin Pressure Clouds Growth

Pediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3%

Pediatrix Medical Group (NYSE:MD) reported Q2 CY2026 results that exceeded revenue and non-GAAP profit expectations, with sales up 4% year-on-year to $487.8 million and adjusted EPS of $0.63. Despite beating estimates, the stock dropped 12.3% post-announcement, indicating investor disappointment. The company highlighted strong performance …

LivaNova PLC stock hits 52-week high at 85.28 USD

LivaNova PLC (LIVN) stock reached a new 52-week high of $85.28, reflecting a 92.84% one-year total return and a market capitalization of $4.68 billion. Despite this surge, InvestingPro analysis suggests the stock is still slightly undervalued. The company also announced strategic leadership changes and …

Concentra Group Holdings Parent, Inc. (NYSE:CON) Given Average Rating of "Moderate Buy" by Brokerages

Concentra Group Holdings Parent, Inc. (NYSE:CON) has received an average "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $31.40. The company recently exceeded earnings expectations, reporting EPS of $0.40 against an estimated $0.35, and revenue of $569.55 million, a …

agilon health, inc. (AGL) withholds shares to cover CLO tax obligations

agilon health, inc. (AGL) Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld on August 1, 2026, to cover income tax obligations related to the net settlement of restricted stock units. This transaction is classified as a tax-withholding disposition, not a …

Addus revenues jump 8%, as personal care and hospice expansion offset home health decline

Addus HomeCare reported an 8% year-over-year revenue increase in Q2 2026, reaching $377.4 million, driven by strong performance in its personal care and hospice divisions. CEO Dirk Allison announced plans for continued growth through mergers and acquisitions, particularly in personal care and home health …

Sei Investments Co. Raises Stock Holdings in Brookdale Senior Living Inc. $BKD

Sei Investments Co. significantly increased its stake in Brookdale Senior Living Inc. during the first quarter, doubling its holdings to 460,330 shares valued at $6.3 million. This comes despite Brookdale Senior Living reporting an adjusted loss and revenue that fell short of analyst expectations …

[DVA Q2 2026 Earnings Call] DaVita to Roll Out Expanded Dialyzers Across Network, Lifts Volume Target to 50-75 Basis Points

DaVita reported Q2 2026 adjusted operating income of $579 million and adjusted EPS of $4.02, meeting expectations, with treatment volume growth accelerating to 56 basis points due to improved mortality. The company announced plans to broadly deploy newly FDA-approved expanded hemodialysis dialyzers following a …

What To Expect From LifeStance Health Group’s (LFST) Q2 Earnings

LifeStance Health Group (LFST) is set to announce its Q2 earnings this Thursday morning. The company previously exceeded revenue expectations in Q1, reporting $403.5 million, and analysts anticipate a 20.1% year-on-year revenue growth for Q2. While peers like DaVita and Centene have reported mixed …

HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against HCA Healthcare, Inc. (NYSE:HCA) on behalf of its stockholders. This investigation follows a significant drop in HCA's stock price after the company lowered its full-2026 profit guidance due to an unfavorable shift in its …

Addus HomeCare Corp 2Q 2026: Revenue $377.42M, EPS $1.49— 10-Q Summary

Addus HomeCare Corp reported its second-quarter 2026 results, showing significant growth in revenue and diluted EPS. The company's revenue increased by 8% to $377.42 million, and diluted EPS rose by 24.2% to $1.49, primarily driven by organic personal care growth and strategic acquisitions. Addus …